Share Prices & Company Research

Market News

11 Oct 2021 | 14:42

Glaxo unveils plans for £120m consumer healhcare HQ ahead of split

(Sharecast News) - GlaxoSmithKline on Monday unveiled plans for a new £120m base for its consumer healthcare operations as it prepares to split into two listed firms.

Around 800 staff in the new firm will relocate to a yet-to-be-constructed building, including research facilities, in Weybridge, southwest of London, from the end of 2024. It will eventually house 1,400 workers.

Staff will first relocate from Glaxo's current corporate headquarters in Brentford, west London, to temporary facilities in Weybridge when the split takes place in mid-2022.

The business is a joint venture with Pfizer, which counts brands such as Sensodyne and Aquafresh toothpastes and Panadol painkillers among its product range.

Glaxo added that it would be selling the Brentford site, with the remaining pharmaceuticals and vaccines staff relocating in the same area, but not until at least the end of 2023.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 17th May 2022
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.